Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erwan Bezard

Showing results (271-280 of 298) with videos related to

Pageof 30
Sort By:
Scientific Reports|June 22, 2019
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson's disease patientsTommaso Nuzzo, Daniela Punzo, Paola Devoto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 27, 2023
Tau seeds from Alzheimer's disease brains trigger tau spread in macaques while oligomeric-Aβ mediates pathology maturationMorgane Darricau, Changsong Dou, Remi Kinet, et al.
Neuron|June 3, 2016
M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced DyskinesiaWeixing Shen, Joshua L Plotkin, Veronica Francardo, et al.
NPJ Parkinson'S Disease|September 19, 2023
Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brainMargaux Teil, Sandra Dovero, Mathieu Bourdenx, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 28, 2007
RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's diseaseStephen J Gold, Chau V Hoang, Bryan W Potts, et al.
Neuron|November 22, 2015
M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced DyskinesiaWeixing Shen, Joshua L Plotkin, Veronica Francardo, et al.
Parkinsonism & Related Disorders|May 12, 2005
Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptorsC Guigoni, I Aubert, Q Li, et al.
NPJ Parkinson'S Disease|August 2, 2025
Position paper: leveraging non-human primate (NHP) specificities to accelerate Parkinson's disease and ageing researchErwan Bezard, Rozalyn M Anderson, Romina Aron Badin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 15, 2018
Inhaling xenon ameliorates l-dopa-induced dyskinesia in experimental parkinsonismJérôme Baufreton, Tomislav Milekovic, Qin Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 2015
Prototypic and arkypallidal neurons in the dopamine-intact external globus pallidusAzzedine Abdi, Nicolas Mallet, Foad Y Mohamed, et al.
Pageof 30

Showing results (271-280 of 298) with videos related to

Sort By:
Pageof 30
Scientific Reports|June 22, 2019
The levels of the NMDA receptor co-agonist D-serine are reduced in the substantia nigra of MPTP-lesioned macaques and in the cerebrospinal fluid of Parkinson's disease patientsTommaso Nuzzo, Daniela Punzo, Paola Devoto, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 27, 2023
Tau seeds from Alzheimer's disease brains trigger tau spread in macaques while oligomeric-Aβ mediates pathology maturationMorgane Darricau, Changsong Dou, Remi Kinet, et al.
Neuron|June 3, 2016
M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced DyskinesiaWeixing Shen, Joshua L Plotkin, Veronica Francardo, et al.
NPJ Parkinson'S Disease|September 19, 2023
Cortical Lewy body injections induce long-distance pathogenic alterations in the non-human primate brainMargaux Teil, Sandra Dovero, Mathieu Bourdenx, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|December 28, 2007
RGS9-2 negatively modulates L-3,4-dihydroxyphenylalanine-induced dyskinesia in experimental Parkinson's diseaseStephen J Gold, Chau V Hoang, Bryan W Potts, et al.
Neuron|November 22, 2015
M4 Muscarinic Receptor Signaling Ameliorates Striatal Plasticity Deficits in Models of L-DOPA-Induced DyskinesiaWeixing Shen, Joshua L Plotkin, Veronica Francardo, et al.
Parkinsonism & Related Disorders|May 12, 2005
Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptorsC Guigoni, I Aubert, Q Li, et al.
NPJ Parkinson'S Disease|August 2, 2025
Position paper: leveraging non-human primate (NHP) specificities to accelerate Parkinson's disease and ageing researchErwan Bezard, Rozalyn M Anderson, Romina Aron Badin, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|May 15, 2018
Inhaling xenon ameliorates l-dopa-induced dyskinesia in experimental parkinsonismJérôme Baufreton, Tomislav Milekovic, Qin Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 2015
Prototypic and arkypallidal neurons in the dopamine-intact external globus pallidusAzzedine Abdi, Nicolas Mallet, Foad Y Mohamed, et al.
Pageof 30